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Abstract
Purpose Greater body fatness has been identified as a risk
factor for postmenopausal breast cancer. For countries with
low overweight/obesity rates, data on prevalence and time
course of overweight/obesity in women with breast cancer
in comparison to women in the general population is lim-
ited. The Swiss female population is distinctive for two
reasons: (a) low rates of overweight/obesity compared with
other western countries, and (b) no obesity epidemic, i.e.
stable rates of overweight/obesity for more than 10 years.
Methods Overweight and obesity were analyzed in 51 to
80-year-old breast cancer patients initially diagnosed
between 1990 and 2009. Patient data was derived from the
Basel Breast Cancer Database (BBCD). This data was
compared with the data of women of the same age from the
four Swiss Health Surveys (SHS) conducted between 1992
and 2007. Differences between measured (BBCD) and self-
reported (SHS) data were corrected using equations
approved for the Swiss population.
Results Of 958 postmenopausal BBCD patients, 32%
were overweight and 20% were obese. Of the 14,476
women of the SHS, 38% were overweight and 17% were
obese. In the BBCD, there was no change in the prevalence
of overweight/obesity over the last 20 years. The four SHS
show a convex curvature for obesity, i.e. a transient
increase. No significant differences were observed between
BBCD and corrected SHS data for overweight and obesity
during this period.
Conclusions In this Swiss study group with a comparably
low prevalence of overweight and obesity, no association
between body fatness and postmenopausal breast cancer
was observed.
Keywords Breast cancer  Overweight  Obesity 
Risk factor  Epidemiology  Swiss Health Survey
Introduction
In 2007, based on an extensive literature review, the
working group World Cancer Research Fund (WCRF)/
American Institute for Cancer Research (AICR) came to
the conclusion that there is consistent epidemiological
evidence and a clear dose response regarding greater body
fatness as a risk factor for postmenopausal breast cancer
[1].
The present study analyses the relationship between
overweight/obesity and breast cancer risk using Swiss data
of a 20-year period. With regard to the prevalence of
obesity, the Swiss female general population is, according
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to the Swiss Health Surveys [2–4], distinctive in two areas
compared to most other industrialized countries [5, 6]:
Switzerland has comparatively low rates of uncorrected
self-reported overweight (22–23%) and obesity (7–8%) of
women aged 18 years and older and has no obesity epi-
demic, i.e. remarkably stable rates of overweight and
obesity over the past 10 years.
As the dose–response relationship between BMI and
postmenopausal breast cancer might be curvilinear (expo-
nential), an increased risk may only be demonstrated in a
population with a high prevalence of obese and very obese
women. Thus it is of interest whether the consistently
shown association between obesity and breast cancer risk
in countries with high obesity prevalence rates [1] can also
be shown in a population with a rather low obesity
prevalence.
Patients and methods
Datasource 1: Basel Breast Cancer Database
The Basel Breast Cancer Database (BBCD) comprises all
newly diagnosed primary invasive breast cancer cases
treated at the University Women’s Hospital Basel,
Switzerland, since 1990. For this study, data from patients
up to and including 2009 were analyzed (n = 1,495). All
data were recorded retrospectively from the medical files.
Recording and storage of the data was done in a web-based
documentation system. Data collection methods and study
design were approved by the Ethical Review.
Datasource 2: Swiss Health Survey
The Swiss Health Survey (SHS) has been conducted on
behalf of the Federal Office of Statistics since 1992 in five-
year intervals. The already existing four surveys, from
1992, 1997, 2002 and in 2007, were each carried out in
representative, randomly selected samples comprising
20,000 to 30,000 private households with a telephone
connection to represent the Swiss permanent population,
i.e. male and female Swiss citizens and foreigners with a
legal work permit aged 15 years and older [7].
Study cohort
In this study, it was our aim to evaluate postmenopausal
women. Although we have close to complete information
regarding the menopausal status of the patients in the
BBCD, we do not have this information in the data from
the SHS. Since the mean age of menopause in the BBCD
was 50.06 years, we used an age-dependent inclusion cri-
terion and analyzed women from 51–80 years of age.
Data on Body Mass Index in BBCD and SHS
In the BBCD, measured weight and height were retrieved
retrospectively from medical files. In the SHS, respondents
were asked in a telephone interview to report their height
(without shoes) and weight (without clothes).
Based on these data, body mass index (BMI = body
weight [kg/height m2]) was calculated and categorized
according to the WHO criteria as follows [8]:
– BMI \18.5: underweight
– BMI 18.5–24.9: normal (desirable) weight
– BMI 25–29.9: overweight
– BMI C30: obesity
In the BBCD, body weight and height have been col-
lected continuously since 1990. However, in the SHS, this
data was collected solely in the four years that the surveys
were performed, namely 1992, 1997, 2002 and 2007. In
order to evaluate BMI distribution time trends over the last
20 years, we defined the four following subgroups:
– BBCD 1990–1994 versus SHS 1992
– BBCD 1995–1999 versus SHS 1997
– BBCD 2000–2004 versus SHS 2002
– BBCD 2005–2009 versus SHS 2007
In this study, we compared objective BMI data (BBCD:
measured) with subjective ones (SHS: self-reported). Since
individuals included in population studies tend to under-
report their weight and overestimate their height, obesity
prevalence based on this data is often inaccurate [9]. Since
over- and underreporting appears to be quite systematic,
correction factors using separate adjustment factors could
increase the accuracy of self-reported estimates [10–12]. In
this study, we used an equation developed by Hayes et al.
[11]. This calculation model was tested and approved for
the Swiss population [13].
Statistical methodology
To allow for non-responders and stratification in relation to
age, gender, and nationality in the four SHS, differences
between the samples and the permanent Swiss population
were mathematically corrected and weighted respectively
with the corresponding formula provided by the Swiss
Federal Office of Statistics [7].
In order to evaluate the time courses for the different
BMI categories, cases were dichotomized with respect to
the corresponding class. As an example: A person
belonging to the category ‘‘overweight’’ was assigned to
the outcome ‘‘1’’ for the outcome variable ‘‘Overweight
Yes/No’’ and to the value ‘‘0’’ for the other binary outcome
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variables ‘‘Underweight Yes/No’’, ‘‘Normal Weight Yes/
No’’ and ‘‘Obesity Yes/No’’.
For each of the binary outcome variables, for both data
sources (BBCD and SHS) the following logistic regression
model was applied:
logit Zij
  ¼ l þ ajðÞ
where the terms in this model are Zij is the Binary
outcome for subject i at year j. 1: if the person belongs to
the corresponding BMI category; 0 else, and l the grand
mean, and aj the effect of year j (factor variable with 4
levels: 1992, 1997, 2002, 2007)
If the overall effect of ‘year’ was significant at the 5%-
level, the linear and quadratic contrasts were tested. The
first one describes a linear (decreasing or increasing) trend,
the second one a possible convex or concave
(‘‘U = shaped’’) time course. For the SHS studies, the data
was weighted to allow for non-responders and stratification
in relation to age, gender, and nationality. The confidence
limits for the weighted frequencies in the SHS studies were
also calculated by means of a logistic model as (*) with
‘‘initial weights’’.
Confidence intervals and tests with unweighted data are
slightly different from the weighted ones presented here;
the interpretation of the results, however, remains the same.
All analyses were conducted using SAS, version 9.1 for
data handling and R, version 2.9, for the calculation of the
statistical models and for the graphical representations.
Results
Of 1,495 patients in the BBCD, 985 (65.7%) were
51–80 years old at diagnosis. Of these, information on BMI
was available for 958 women and, thus, was analyzed in
the study; the mean age of this study subgroup was
65.0 years. From the 35,090 women who were interviewed
in the SHS and provided information on BMI, 14,476
women (37.2%) met our age-dependent inclusion criteria;
the mean, weighted age of this subgroup was 63.7 years.
BMI distribution in women of the BBCD and the SHS
BMI distributions of the BBCD and the SHS study cohorts
are shown in Table 1. Of the BBCD group, 309 women
(32.3%) were overweight (BMI 25–29.9) and 188 women
(19.6%) were obese (BMI 30 ?) at the time of the initial
breast cancer diagnosis. In comparison, of women of the
same age in the overall group of the SHS 1992–2007
(n = 14,476), 37.7% were overweight and 17.0% were
obese (corrected for self-report [11, 13]).
How did the BMI distribution develop over the last
20 years?
During the four time periods considered in the BBCD
(1990–94, 1995–99, 2000–04, 2005–09), the prevalence of
overweight were 35.5, 36.3, 31.3 and 27.8%, respectively;
the prevalence of obesity were 15.0, 23.8, 18.9, and 21.2%,
respectively. (Table 2, Fig. 1). For 51 to 80-year-old
women of the four SHS of 1992, 1997, 2002 and 2007, the
corresponding prevalence for overweight and obesity,
corrected for self-report [11, 13], were 38.6, 37.8, 38.5,
36.2 and 12.9, 19.5, 17.4 and 17.7%, respectively.
Statistical tests for the overall time course over the four
periods revealed a comparable pattern in all tested cate-
gories of the SHS and the BBCD, respectively (Table 2).
For ‘‘overweight’’, the tests for the overall time course
were not statistically significant. For ‘‘obesity’’, the test for
the overall time course was highly significant in the SHS;
the corresponding linear contrast was positive and statis-
tically significant, indicating an increase over time. Addi-
tionally, the quadratic contrast was significant and
Table 1 BMI distribution in 51–80 years old women of the Basel Breast Cancer Database (BBCD) between 1990 and 2009 in comparison to
women of the same age in the Swiss Health Surveys (SHS) 1992–2007
Body Mass Index BBCD 1990–2009 SHS 1992–2007a
N % Nb %
Underweight BMI \18.5 kg/m2 22 2.3 203 1.4
Normal weight BMI 18.5–24.9 kg/m2 439 45.8 6,355 43.9
Overweight BMI 25–29.9 kg/m2 309 32.3 5,457 37.7
Obesity BMI 30 ? kg/m2 188 19.6 2,461 17.0
a Datasource: Swiss Federal Office (FSO); data corrected for self-report [13]; weighted to allow for non-responders and stratification in relation
to age, gender and nationality
b Unweighted N
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negative, indicating a convex curvature, as can be seen in
Fig. 1. For the BBCD data, however, the test for the overall
time course was not statistically significant.
Was there a higher prevalence of overweight and obesity
in patients with breast cancer than in women of the general
population?
Overall, there was no evidence of statistically significant
differences between BBCD data and corrected and
weighted SHS data in relation to overweight and obesity
over the four time periods considered (Table 3).
Discussion
Body fatness increases blood levels of a number of hor-
mones, such as estrogens, insulin-like growth factors and
insulin, thereby creating an environment that facilitates
carcinogenesis [14]. Multiple epidemiological lines of
evidence have shown that overweight and obesity pose a
risk factor for postmenopausal breast cancer. In a meta-
analysis conducted in 2007 by the WCRF/AICR on the
basis of 17 cohort and 48 case–control studies, the authors
Table 2 Statistical tests to evaluate the overall time course of overweight and obesity prevalence in 51 to 80-year-old women of the BBCD from
1990 to 2009 in comparison to women of the same age in the SHS 1992, 1997, 2002 and 2007
Study group BMI category 1990–2007
‘‘year’’ (overall
time course)
Linear trend Quadratic trend
BBCDa,b Overweight ns
Obesity ns
SHSc,d,e,f Overweight ns
Obesity *** ?; *** -; ***
ns statistically not significant, ***p \ 0.001, ? a positive linear trend or a concave quadratic trend, - a negative linear trend or a convex
quadratic trend
a BBCD Basel Breast Cancer Database
b Compared time periods: 1990–1994, 1995–1999, 2000–2004, 2005–2009
c SHS Swiss Health Survey, Datasource: Swiss Federal Office (FSO)
d Weighted to allow for non-responders and stratification in relation to age, gender, and nationality
e Compared time periods 1992, 1997, 2002, 2007
f Data corrected for self-report [13]
Fig. 1 BMI distribution in
51–80 years old women of the
Basel Breast Cancer Database
(BBCD) between 1990 and
2009 in comparison to women
of the same age in the Swiss
Health Surveys (SHS, corrected
for self-report [13]). Datasource
of the SHS: Swiss Federal
Office (FSO); 1997,
underweight n = 28 weighted,
with 95% CI 1992, 1997, 2002,
and 2007
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calculated a summary effect estimate of 1.03 (95% CI
1.01–1.04) and 1.05 (95% CI 1.05–1.06) per 2 kg/m2
increase in BMI, respectively [1]. Therefore, one would
expect that, relating to a defined population of postmeno-
pausal women, there are more overweight and obese
women in a breast cancer cohort than in the general pop-
ulation. In the present analysis no such difference was
observed for the Swiss study group. Out of the postmen-
opausal breast cancer patients of the BBCD, 32% were
overweight and 20% were obese. This data is comparable
with a group of 337 breast cancer patients [50 years who
were registered in the canton of Geneva between 2003 to
2005 and of which 28% were overweight and 21% were
obese [15]. In comparison, of the 51 to 80 years old women
of the overall group of the SHS 1992 to 2007, 38% were
overweight and 17% were obese (corrected for self-report
[11, 13]). In the BBCD, the overweight/obesity rates have
been more or less consistent over the last 20 years. In the
course of the four SHS, a convex pattern, i.e. transient
increase in the prevalence of obesity was observed. For the
whole group of women in the SHS, i.e. including women
18 years and older, overweight and obesity increased
between 1992 and 1997, but between 1997 and 2007,
however, no statistically significant increase was observed
anymore [4]. Likewise, in a cross-sectional repeated survey
of adults aged 35–74 years in Geneva, obesity prevalence
did not increase significantly in women between 1993 and
2004 [16]. This data contradicts that of most other
industrialized countries which have been affected by a
considerable rise in obesity prevalence (‘‘global epi-
demic’’) [17–22]. Compared to the USA, the obesity rates
in Switzerland are actually half as high [6].
A possible explanation for the fact that our data is not in
alignment with most other studies analyzing the
relationship between body fatness and postmenopausal
breast cancer could be due to the lower prevalence of
female overweight and obesity in comparison to other
European countries [5, 22]. In the four Swiss Health Sur-
veys in women aged 18 years and older rates of uncor-
rected self-reported overweight were between 22 and 23%
and of obesity between 7 and 8% [4]. Data of the Inter-
national Association for the Study of Obesity (IASO) on
self-reported weight and height, collected in women
between 1997 and 2008 in the European Union, revealed
prevalence of overweight between 24% in Belgium and
34% in Malta and of obesity between 9% in Italy and 19%
in Slovakia. The surveys used in this overview were not
strictly comparable because of differences in age range and
methodology [5]. However, the Swiss population is, in
general as well as in different analyses taking into account
gender- and age-specific subgroups, clearly at the lower
end of this list.
As already mentioned, measured BMI data of the BBCD
and BMI data of the SHS corrected for self-report revealed
for women aged 51–80 years overweight prevalence of 32
and 38% and of obesity of 20 and 17%. These quite high
levels of overweight and obesity in comparison to the ones
of women aged 18 years and more of the SHS most
probably reflect the rather high average age of this group
and the well-known increase of overweight prevalence
with increasing age [4].
Findings from countries with high overweight/obesity
prevalence (approximately 50% of the cohort studies
compiled in the WCRF/AICR review stem from the USA
[1]) may not unconditionally be applied to populations with
comparably rather low overweight/obesity prevalence such
as Switzerland. For example, in the USA there are signif-
icantly more women with excessive body fatness, a
Table 3 Overweight (BMI 25–29.9) and obesity (BMI 30?) in 51–80 years old postmenopausal women of the BBCD from 1990 to 2009 in
comparison to women of the same age in the SHS 1992, 1997, 2002 and 2007
Time period Study group Overweight Obesity
% 95% CI % 95% CI
1990–1994 BBCDa 35.5 29.4–42.0 15.0 10.6–20.2
1992 SHSb,c,d 38.6 37.3–39.8 12.9 12.4–13.5
1995–1999 BBCDa 36.3 29.5–43.5 23.8 18.0–30.5
1997 SHSb,c,d 37.8 36.5–39.1 19.5 18.8–20.3
2000–2004 BBCDa 31.3 25.5–37.5 18.9 14.2–24.4
2002 SHSb,c,d 38.5 37.4–39.6 17.4 16.8–18.0
2005–2009 BBCDa 27.8 22.7–33.3 21.2 16.6–26.4
2007 SHSb,c,d 36.2 35.2–37.3 17.7 17.1–18.3
a BBCD Basel Breast Cancer Database
b SHS Swiss Health Survey; Datasource: Swiss Federal Office (FSO)
c Weighted to allow for non-responders and stratification in relation to age, gender, and nationality
d Data corrected for self-report [13]
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condition which may indicate a considerably different
lifestyle, including numerous other factors that might also
facilitate carcinogenesis. However, these factors can hardly
be controlled for. A limitation of the present study is that
no control for potential confounders other than age was
possible.
Another possible explanation for the fact that in our
study no association between overweight and obesity and
postmenopausal breast cancer could be demonstrated may
be the possibility of a curvilinear dose–response relation-
ship between BMI and postmenopausal breast cancer risk
[1], such that an increased risk may only be observed in
population with a high prevalence of obese and very obese
women.
Furthermore, body measurements that describe central
obesity such as waist circumference and the waist-to-hip
ratio might reflect the increased hazards of fat tissue related
to increased breast cancer risk (i.e. to increase the bioac-
tivity of circulating estrogens) better than the BMI alone
[23].
In addition, overweight might be associated with an
increased risk of postmenopausal breast cancer, especially
among those who have never used hormone replacement
therapy (HRT) [24]. In the BBCD, restriction of the anal-
yses on women without HRT (64%) (with HRT: 19%,
unknown: 17%) was only possible for the overall group of
breast cancer patients and revealed that 34% of women
without HRT were overweight and 20% were obese;
detailed analyses on time trends etc. were impossible due
to the limited number of breast cancer cases.
Furthermore, our study, as most of the other epidemio-
logical studies conducted so far, could not discriminate
between the hormonal receptor positive and negative breast
cancer.
Finally, unintentional weight loss related to their breast
cancer in women of the BBCS can be excluded as an
explanation of our negative results, because very few
patients presented cancer-related cachexia.
Two other critical points must be considered in the
interpretation of our data. Firstly, it is important to note
that in the BBCD, women’s weight and height were mea-
sured directly. In the SHS, on the contrary, this data was
collected in a telephone interview, i.e. was self-reported. It
is a well-known fact that self-reported body height is often
overestimated and weight is underestimated and that
therefore the BMI is underestimated [9, 25–27]. World-
wide, studies have been carried out to estimate the gap
between self-reported and measured BMI data and cor-
rection equations have been proposed, e.g. [10–12]. These
equations consider several population-specific selective
criteria [27]. Using such an equation, it must be assured
that it is applicable for the particular population analyzed.
Comparing different methods of adjustment for the Swiss
population, Fa¨h et al. [13] came to the conclusion, that
equation adjustment had advantages over the use of an
universal lower cut-off level. The authors tested several
calculation models for correcting self-reported weight and
height and found that by using correction equations from
Hayes et al. [11] the self-reported data corresponded best to
the measured ones in Switzerland [13]. As this equation
was defined to represent Swiss characteristics, we used it in
our study.
Secondly, many breast cancer studies do not use age-
dependent subgroups but differentiate between the men-
opausal status (pre- or postmenopausal). Our aim was to
evaluate the group of postmenopausal women. Although
we possessed almost complete information regarding the
menopausal status of the patients in the BBCD, we did
not have this information in the data from the SHS. Since
the mean age of menopause in the BBCD was
50.06 years, we used the above-mentioned subdivision of
age in our study.
We are aware of the fact that using this method would
lead certain patients being included ([51 years, premeno-
pausal) or excluded (\51 years, postmenopausal) in a
debatable way. However, with respect to the entire study
group (n = 958), the number of such patients is so small,
that they should not have a significant effect on the
reported results. Furthermore, a certain variance in time
will hardly lead to the fact that the women will be classified
into another BMI classification subgroup, which was our
target variable in this study. In general, there is an
increasing awareness both by clinicians and epidemiolo-
gists of the fact that in the evaluation of cohorts which are
defined and differentiated by the menopausal status, a grey
area in the transition between pre- and postmenopause is
unavoidable, since a certain number of women can barely
be fitted into a theoretical framework (e.g., the menopausal
status is unclear due to the history of hysterectomy in the
premenopausal situation or the application of hormonal
measures) [28, 29].
In conclusion, we did not observe higher rates of over-
weight and obesity in breast cancer cases than in the gen-
eral population. Thus, in our Swiss study group with
comparably low prevalence rates of overweight and obes-
ity, we could not show an association of overweight and
obesity with postmenopausal breast cancer.
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